Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells

Mesenchymal stem cells have been implicated as playing an important role in stem cell engraftment. Recently, a new pluripotent population of umbilical cord blood ( UCB) cells, unrestricted somatic stem cells ( USSCs), with intrinsic and directable potential to develop into mesodermal, endodermal, and ectodermal fates, has been identified. In this study, we evaluated the capacity of ex vivo expanded USSCs to influence the homing of UCB-derived CD34(+) cells into the marrow and spleen of nonobese diabetic/ severe combined immunodeficient ( NOD/ SCID) mice. USSCs induced a significant enhancement of CD34(+) cell homing to both bone marrow and spleen ( 2.2 +/- 0.3- and 2.4 +/- 0.6- fold, respectively; p <.05), with a magnitude similar to that induced by USSCs that had been thawed prior to transplantation. The effect of USSCs was dose- dependent and detectable at USSC: CD34(+) ratios of 1: 1 and above. Enhanced marrow homing by USSCs was unaltered by extensive culture passaging of the cells, as similar enhancement was observed for both early-passage ( passage 5 [ p5]) and late- passage ( p10) USSCs. The homing effect of USSCs was also reflected in an increased proportion of NOD/ SCID mice exhibiting significant human cell engraftment 6 weeks after transplantation, with a similar distribution of myeloid and lymphoid components. USSCs enhanced the homing of cellular products of ex vivo expanded UCB lineage-negative ( lin(-)) cells, generated in 14-day cultures by Selective Amplification. The relative proportion of homing CD34(+) cells within the culture- expanded cell population was unaltered by USSC cotransplantation. Production of stromal-derived factor-1 ( SDF-1) by USSCs was detected by both gene expression and protein released into culture media of these cells. Knockdown of SDF-1 production by USSCs using lentiviral-SiRNA led to a significant ( p <.05) reduction in USSC- mediated enhancement of CD34(+) homing. Our findings thus suggest a clinical potential for using USSCs in facilitating homing and engraftment for cord blood transplant recipients.